Direxion Daily QCOM Bull 2X Shares

QCMU
  • Weekly Recap | Qualcomm +2.21%, beating the S&P 500

    Weekly Review·
    - Qualcomm's stock rose 2.21% to close at 175.91 dollars this week, outperforming the S&P 500 index. - Key corporate developments included winning a legal battle against Arm with a nominal 2 dollars award, announcing global performance-based layoffs, and declaring a quarterly cash dividend of 0.92 dollars per share. - Institutional analysts maintained a neutral consensus rating with a target price of 195.8 dollars, while upcoming events will focus on the fiscal Q4 earnings release on November 4.
  • Weekly Recap | Qualcomm -1.93%, Arm verdict leaves royalty fight open

    Weekly Review·
    - Qualcomm stock fell 1.93 % to close at 172.11 dollars this week, roughly in line with the S & P 500. - A Delaware jury ruled that Arm breached a licensing agreement but awarded Qualcomm only 2 dollars in damages. - Qualcomm expanded its edge AI and Wi-Fi 8 partnerships while preparing to release its fiscal Q4 earnings next week.
  • Weekly Recap | Qualcomm -5.07%, Huawei licence deal, Arm verdict in focus

    Weekly Review·
    - Qualcomm shares fell 5.07% this week to close at 175.5 US dollars, underperforming the S & P 500 amid broader semiconductor sector corrections. - Key corporate developments included a patent cross-licensing agreement with Huawei, a 6G technology showcase with Tejas Networks, and market caution ahead of an upcoming Arm contract dispute jury verdict. - Institutional sentiment remained neutral with a consensus target price of 194.13 US dollars, while investors await upcoming inflation data and the Q4 fiscal earnings report on November 4.
  • Weekly Recap | Qualcomm -8.47%, moving on $60bn AI-chip fundraise

    Weekly Review·
    - Qualcomm accumulated an 8.47 % drop this week to close at 184.87 dollars, significantly underperforming the S & P 500. - The company launched a 60 billion dollar financing initiative for AI chips to support firms like Anthropic in procurement. - Institutional ratings remained generally neutral with a consensus target price of 194.13 dollars, while upcoming macroeconomic data and Q4 earnings will guide future valuation.